Table 5.

Use of cobas-like partial HPV typing in cotesting

HPV-type positiveHPV-type negative
3-Year risk of CIN3+95% CI3-Year risk of CIN3+95% CI
HPV1610.3%9.6%–11.1%2.3%2.2%–2.4%
HPV185.0%4.3%–5.8%2.1%2.0%–2.2%
HPV HR2.3%2.2%–2.5%1.4%1.4%–1.6%

NOTE: The estimated CIN3+ risk among all women ages 30 years and older testing HC2+ with negative cytology, prior to typing, was 3.5%; by current U.S. guidelines all would be recommended to return for retesting in 1 year. Three-year cumulative risk of CIN3 or worse (CIN3+) among women with Hybrid Capture 2–positive (HC2+) negative cytology, ages 30 years and older, stratified by HPV type status [HPV16, else HPV18, else other 12 high-risk (HR) types targeted by cobas].